Beyond gene discovery in inflammatory bowel disease: The emerging role of epigenetics

Gastroenterology

Volumn 145, Issue 2, 2013, Pages 293-308

  Ventham, Nicholas T ^a   Kennedy, Nicholas A ^a   Nimmo, Elaine R ^a   Satsangi, Jack ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Epigenetics Crohn's Disease Ulcerative Colitis DNA Methylation

Indexed keywords

ALKALINE PHOSPHATASE; APICIDIN; BENZAMIDE; BUTYRIC ACID; DEPSIPEPTIDE; DNA METHYLTRANSFERASE 3B; ENTINOSTAT; GIVINOSTAT; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; HLA DQA1 ANTIGEN; HYDROXAMIC ACID DERIVATIVE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 23; INTERLEUKIN 23 RECEPTOR; JANUS KINASE 2; KBH A 42; MESALAZINE; MESSENGER RNA; MICRORNA; MOCETINOSTAT; STAT3 PROTEIN; STAT4 PROTEIN; TRICHOSTATIN A; UNCLASSIFIED DRUG; UVOMORULIN; VALPROIC ACID; VORINOSTAT;

ALLELE; ANKYLOSING SPONDYLITIS; ANTIINFLAMMATORY ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; DNA METHYLATION; DNA SEQUENCE; ENTERITIS; ENTEROCOLITIS; EPIGENETICS; GENE EXPRESSION; GENE INTERACTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETICS; HAPLOTYPE; HEREDITY; HISTONE ACETYLATION; HISTONE MODIFICATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PHENOTYPE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS;

EID: 84880595486     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2013.05.050     Document Type: Review

References (154)

1. N.A. Molodecky, I.S. Soon, and D.M. Rabi Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review Gastroenterology 142 2012 46 54.e42 quiz e30
2. P. Henderson, R. Hansen, and F.L. Cameron Rising incidence of pediatric inflammatory bowel disease in Scotland Inflamm Bowel Dis 18 2012 999 1005
3. E.I. Benchimol, A. Guttmann, and A.M. Griffiths Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data Gut 58 2009 1490 1497
4. S.C. Ng, C.N. Bernstein, and M.H. Vatn Geographical variability and environmental risk factors in inflammatory bowel disease Gut 62 2013 630 649
5. S. Gunesh, G.A. Thomas, and G.T. Williams The incidence of Crohn's disease in Cardiff over the last 75 years: an update for 1996-2005 Aliment Pharmacol Ther 27 2008 211 219
6. IBD Standards Group UK Quality care cervice standards for the healthcare of people who have inflammatory bowel disease 2009 Available at: http://www.ibdstandards.org.uk/ibd-standards.asp Accessed March 1, 2013
7. M.E. van der Valk, M.-J.J. Mangen, and M. Leenders Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study Gut 2012 Nov 7 [Epub ahead of print]
8. R.J. Xavier, and D.K. Podolsky Unravelling the pathogenesis of inflammatory bowel disease Nature 448 2007 427 434
9. L. Jostins, S. Ripke, and R.K. Weersma Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease Nature 490 2012 119 124
10. J. Van Limbergen, C. Stevens, and E.R. Nimmo Autophagy: from basic science to clinical application Mucosal Immunol 2 2009 315 330
11. B. Khor, A. Gardet, and R.J. Xavier Genetics and pathogenesis of inflammatory bowel disease Nature 474 2011 307 317
12. C.A. Anderson, G. Boucher, and C.W. Lees Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47 Nat Genet 43 2011 246 252
13. S. Brand Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease Gut 58 2009 1152 1167
14. A. Franke, T. Balschun, and T.H. Karlsen Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility Nat Genet 40 2008 1319 1323
15. A. Franke, D.P.B. Mcgovern, and J.C. Barrett Meta-analysis increases to 71 the tally of confirmed Crohn's disease susceptibility loci Nat Genet 42 2010 1118 1125
16. E.-O. Glocker, D. Kotlarz, and K. Boztug Inflammatory bowel disease and mutations affecting the interleukin-10 receptor N Engl J Med 361 2009 2033 2045
17. E.-O. Glocker, N. Frede, and M. Perro Infant colitis - it's in the genes Lancet 376 2010 1272
18. J.C. Barrett, S. Hansoul, and D.L. Nicolae Genome-wide association defines more than thirty distinct susceptibility loci for Crohn's disease Nat Genet 40 2009 955 962
19. R. Cooney, J. Baker, and O. Brain NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation Nat Med 16 2010 90 97
20. L.H. Travassos, L.A.M. Carneiro, and M. Ramjeet Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry Nat Immunol 11 2010 55 62
21. M.C. Aldhous, K. Soo, and L.A. Stark Cigarette smoke extract (CSE) delays NOD2 expression and affects NOD2/RIPK2 interactions in intestinal epithelial cells PloS One 6 2011 e24715
22. J.H. Cho, and S.R. Brant Recent insights into the genetics of inflammatory bowel disease Gastroenterology 140 2011 1704 1712
23. C.D. Intemann, T. Thye, and S. Niemann Autophagy gene variant IRGM -261T contributes to protection from tuberculosis caused by Mycobacterium tuberculosis but not by M. africanum strains PLoS Pathog 5 2009 e1000577
24. J.C. Barrett, J.C. Lee, and C.W. Lees Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region Nat Genet 41 2009 1330 1334
25. K. Yamagata, H. Furuta, and N. Oda Mutations in the hepatocyte nuclear factor-4gene in maturity-onset diabetes of the young (MODY1) Nature 384 1996 458 460
26. M. Cargill, S.J. Schrodi, and M. Chang A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes Am J Hum Genet 80 2007 273 290
27. P. Burton, D. Clayton, and L. Cardon Association scan of 14,500 nsSNPs in four common diseases identifies variants involved in autoimmunity Nat Genet 39 2009 1329 1337
28. J.H. Cho, and P.K. Gregersen Genomics and the multifactorial nature of human autoimmune disease N Engl J Med 365 2011 1612 1623
29. C.W. Lees, J.C. Barrett, and M. Parkes New IBD genetics: common pathways with other diseases Gut 60 2011 1739 1753
30. K. Wang, R. Baldassano, and H. Zhang Comparative genetic analysis of inflammatory bowel disease and type 1 diabetes implicates multiple loci with opposite effects Hum Mol Genet 19 2010 2059 2067
31. K. Muriboberg, E. Melum, and T. Folseraas Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL and CARD9 Hepatology 53 2012 1977 1985
32. E.A. Worthey, A.N. Mayer, and G.D. Syverson Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease Genet Med 13 2011 255 262
33. I. Dunham, A. Kundaje, and S.F. Aldred An integrated encyclopedia of DNA elements in the human genome Nature 489 2012 57 74
34. T. Ahmad, A. Armuzzi, and M. Bunce The molecular classification of the clinical manifestations of Crohn's disease Gastroenterology 122 2002 854 866
35. S. Futami, N. Aoyama, and Y. Honsako HLA-DRB1*1502 allele, subtype of DR15, is associated with susceptibility to ulcerative colitis and its progression Dig Dis Sci 40 1995 814 818
36. S. Lesage, H. Zouali, and J.-P. Cézard CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease Am J Hum Genet 70 2002 845 857
37. C.W. Lees Characterization of the ∼40,000 patient cohort of the International Inflammatory Bowel Disease Genetics Consortium (IIBDGC) J Crohn's Colitis 7 2013 S4
38. S.R. Brant Promises, delivery, and challenges of inflammatory bowel disease risk gene discovery Clin Gastroenterol Hepatol 11 2012 22 26
39. T. Dassopoulos, G.C. Nguyen, and M.V. Talor NOD2 mutations and anti-Saccharomyces cerevisiae antibodies are risk factors for Crohn's disease in African Americans Am J Gastroenterol 105 2010 378 386
40. N. Inoue Lack of common NOD2 variants in Japanese patients with Crohn's disease Gastroenterology 123 2002 86 91
41. US Food and Drug Administration Imuran (azathioprine) product information Drugs@FDA 2011 1-9
42. R.L. Roberts, and M.L. Barclay Current relevance of pharmacogenetics in immunomodulation treatment for Crohn's disease J Gastroenterol Hepatol 27 2012 1546 1554
43. W.J. Sandborn, C. Gasink, and L.-L. Gao Ustekinumab induction and maintenance therapy in refractory Crohn's disease N Engl J Med 367 2012 1519 1528
44. S. Danese New therapies for inflammatory bowel disease: from the bench to the bedside Gut 61 2012 918 932
45. A. Petronis Epigenetics as a unifying principle in the aetiology of complex traits and diseases Nature 465 2010 721 727
46. H.D. Morgan, H.G.E. Sutherland, and D.I.K. Martin Epigenetic inheritance at the agouti locus in the mouse Nat Genet 23 2006 314 318
47. T.D. Schaible, R.A. Harris, and S.E. Dowd Maternal methyl-donor supplementation induces prolonged murine offspring colitis susceptibility in association with mucosal epigenetic and microbiomic changes Hum Mol Genet 20 2011 1687 1696
48. R.A. Waterland, and R.L. Jirtle Transposable elements: targets for early nutritional effects on epigenetic gene regulation Mol Cell Biol 23 2003 5293 5300
49. E.W. Tobi, L.H. Lumey, and R.P. Talens DNA methylation differences after exposure to prenatal famine are common and timing- and sex-specific Hum Mol Genet 18 2009 4046 4053
50. B.T. Heijmans, E.W. Tobi, and L.H. Lumey Archive of the prenatal environment Epigenetics 4 2009 526 531
51. C.L. Relton, and G. Davey Smith Epigenetic epidemiology of common complex disease: prospects for prediction, prevention, and treatment PLoS Med 7 2010 e1000356
52. O. Brain, P. Allan, and T. Pichulik NOD2 regulation of micrornas Gut 60 2011 A37 A37
53. P.C.J. Janson, M.E. Winerdal, and O. Winqvist At the crossroads of T helper lineage commitment - epigenetics points the way Biochim Biophys Acta 1790 2009 906 919
54. C. Faulk, and D.C. Dolinoy Timing is everything: the when and how of environmentally induced changes in the epigenome of animals Epigenetics 6 2011 791 797
55. M. De Santis, and C. Selmi The therapeutic potential of epigenetics in autoimmune diseases Clin Rev Allergy Immunol 42 2012 92 101
56. T. Ushijima, N. Watanabe, and E. Okochi Fidelity of the methylation pattern and its variation in the genome Genome Res 13 2003 868 874
57. S.A. Smallwood, and G. Kelsey De novo DNA methylation: a germ cell perspective Trends Genet 28 2012 33 42
58. M.E. Blewitt, N.K. Vickaryous, and A. Paldi Dynamic reprogramming of DNA methylation at an epigenetically sensitive allele in mice PLoS Genet 2 2006 e49
59. U. Grossniklaus, B. Kelly, and A.C. Ferguson-Smith Transgenerational epigenetic inheritance: how important is it? Nat Rev Genet 14 2013 228 235
60. N. Lane, W. Dean, and S. Erhardt Resistance of IAPs to methylation reprogramming may provide a mechanism for epigenetic inheritance in the mouse Genesis 35 2003 88 93
61. P. Cubas, C. Vincent, and E. Coen An epigenetic mutation responsible for natural variation in floral symmetry Nature 401 1999 157 161
62. N.A. Youngson, and E. Whitelaw Transgenerational epigenetic effects Annu Rev Genomics Hum Genet 9 2008 233 257
63. A. Portela, and M. Esteller Epigenetic modifications and human disease Nat Biotechnol 28 2010 1057 1068
64. A. Doi, I. Park, and B. Wen Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts Nat Genet 41 2010 1350 1353
65. T. Hughes, R. Webb, and Y. Fei DNA methylome in human CD4+ T cells identifies transcriptionally repressive and non-repressive methylation peaks Genes Immun 11 2010 554 560
66. A. Kuroda, T.A. Rauch, and I. Todorov Insulin gene expression is regulated by DNA methylation PloS One 4 2009 e6953
67. S.J. Clark, and J. Melki DNA methylation and gene silencing in cancer: which is the guilty party? Oncogene 21 2002 5380 5387
68. T. Kouzarides Chromatin modifications and their function Cell 128 2007 693 705
69. Z. Wang, C. Zang, and J.A. Rosenfeld Combinatorial patterns of histone acetylations and methylations in the human genome Nat Genet 40 2008 897 903
70. M.D. Shahbazian, and M. Grunstein Functions of site-specific histone acetylation and deacetylation Annu Rev Biochem 76 2007 75 100
71. T. Latham, L. Mackay, and D. Sproul Lactate, a product of glycolytic metabolism, inhibits histone deacetylase activity and promotes changes in gene expression Nucleic Acids Res 40 2012 4794 4803
72. R.M. O'Connell, D.S. Rao, and A.A. Chaudhuri Physiological and pathological roles for microRNAs in the immune system Nat Rev Immunol 10 2010 111 122
73. D.P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
74. S.R. Dalal, and J.H. Kwonc The role of microRNA in inflammatory bowel disease Gastroenterol Hepatol 6 2010 714 722
75. D. Baek, J. Villén, and C. Shin The impact of microRNAs on protein output Nature 455 2009 64 71
76. V.K. Rakyan, T.A. Down, and D.J. Balding Epigenome-wide association studies for common human diseases Nat Rev Genet 12 2011 529 541
77. A.W. Drong, C.M. Lindgren, and M.I. McCarthy The genetic and epigenetic basis of type 2 diabetes and obesity Clin Pharmacol Ther 92 2012 707 715
78. Y. Liu, M.J. Aryee, and L. Padyukov Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis Nat Biotechnol 31 2013 142 147
79. E.R. Nimmo, J.G. Prendergast, and M.C. Aldhous Genome-wide methylation profiling in Crohn's disease identifies altered epigenetic regulation of key host defense mechanisms including the Th17 pathway Inflamm Bowel Dis 18 2012 889 899
80. J.P. Issa, N. Ahuja, and M. Toyota Accelerated age-related CpG island methylation in ulcerative colitis Cancer Res 61 2001 3573 3577
81. S. Saito, J. Kato, and S. Hiraoka DNA methylation of colon mucosa in ulcerative colitis patients: correlation with inflammatory status Inflamm Bowel Dis 17 2011 1955 1965
82. P. Azarschab, R. Porschen, and M. Gregor Epigenetic control of the E-cadherin gene (CDH1) by CpG methylation in colectomy samples of patients with ulcerative colitis Genes Chromosomes Cancer 35 2002 121 126
83. J.M. Wheeler, H.C. Kim, and J.A. Efstathiou Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer Gut 48 2001 367 371
84. R.A. Harris, D. Nagy-Szakal, and N. Pedersen Genome-wide peripheral blood leukocyte DNA methylation microarrays identified a single association with inflammatory bowel diseases Inflamm Bowel Dis 18 2012 2334 2341
85. Z. Lin, J.P. Hegarty, and W. Yu Identification of disease-associated DNA methylation in B cells from Crohn's disease and ulcerative colitis patients Dig Dis Sci 57 2012 3145 3153
86. R. Häsler, Z. Feng, and L. Bäckdahl A functional methylome map of ulcerative colitis Genome Res 22 2012 2130 2137
87. J. Cooke, H. Zhang, and L. Greger Mucosal genome-wide methylation changes in inflammatory bowel disease Inflamm Bowel Dis 18 2012 2128 2137
88. S. Saccani, and G. Natoli Dynamic changes in histone H3 Lys 9 methylation occurring at tightly regulated inducible inflammatory genes Genes Dev 16 2002 2219 2224
89. L.G. Tsaprouni, K. Ito, and J.J. Powell Differential patterns of histone acetylation in inflammatory bowel diseases J Inflamm 8 2011 1
90. C.-H. Leung, W. Lam, and D.-L. Ma Butyrate mediates nucleotide-binding and oligomerisation domain (NOD) 2-dependent mucosal immune responses against peptidoglycan Eur J Immunol 39 2009 3529 3537
91. M.S. Malo, S. Biswas, and M.A. Abedrapo The pro-inflammatory cytokines, IL-1beta and TNF-alpha, inhibit intestinal alkaline phosphatase gene expression DNA Cell Biol 25 2006 684 695
92. K. Takahashi, Y. Sugi, and A. Hosono Epigenetic regulation of TLR4 gene expression in intestinal epithelial cells for the maintenance of intestinal homeostasis J Immunol 183 2009 6522 6529
93. L. Yin, and W.O. Chung Epigenetic regulation of human β-defensin 2 and CC chemokine ligand 20 expression in gingival epithelial cells in response to oral bacteria Mucosal Immunol 4 2011 409 419
94. S.J. Shuttleworth, S.G. Bailey, and P.A. Townsend Histone Deacetylase inhibitors: new promise in the treatment of immune and inflammatory diseases Curr Drug Targets 11 2010 1430 1438
95. M.A. Halili, M.R. Andrews, and M.J. Sweet Histone deacetylase inhibitors in inflammatory disease Curr Top Med Chem 9 2009 309 319
96. R. Glauben, and B. Siegmund Inhibition of histone deacetylases in inflammatory bowel diseases Mol Med 17 2011 426 433
97. J.-S. Park, E.-J. Lee, and J.-C. Lee Anti-inflammatory effects of short chain fatty acids in IFN-gamma-stimulated RAW 264.7 murine macrophage cells: involvement of NF-kappaB and ERK signaling pathways Int Immunopharmacol 7 2007 70 77
98. W.S. Xu, and R.B. Parmigiani Marks P a. Histone deacetylase inhibitors: molecular mechanisms of action Oncogene 26 2007 5541 5552
99. R. Tao, E.F. de Zoeten, and E. Ozkaynak Deacetylase inhibition promotes the generation and function of regulatory T cells Nat Med 13 2007 1299 1307
100. F.L. Chen, W. Fischle, and E. Verdin Duration of nuclear NF-kappaB action regulated by reversible acetylation Science 293 2001 1653 1657
101. R. Glauben, A. Batra, and T. Stroh Histone deacetylases: novel targets for prevention of colitis-associated cancer in mice Gut 57 2008 613 622
102. K. Ito, S. Yamamura, and S. Essilfie-Quaye Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression J Exp Med 203 2006 7 13
103. J.D. Butzner, R. Parmar, and C.J. Bell Butyrate enema therapy stimulates mucosal repair in experimental colitis in the rat Gut 38 1996 568 573
104. R. Glauben, A. Batra, and I. Fedke Histone hyperacetylation is associated with amelioration of experimental colitis in mice J Immunol 176 2006 5015 5022
105. S. Plöger, F. Stumpff, and G.B. Penner Microbial butyrate and its role for barrier function in the gastrointestinal tract Ann N Y Acad Sci 1258 2012 52 59
106. H. Lührs, T. Gerke, and J.G. Müller Butyrate inhibits NF-kappaB activation in lamina propria macrophages of patients with ulcerative colitis Scand J Gastroenterol 37 2002 458 466
107. L.B. McKenna, J. Schug, and A. Vourekas MicroRNAs control intestinal epithelial differentiation, architecture, and barrier function Gastroenterology 139 2010 1654 1664 1664.e1
108. F. Wu, M. Zikusoka, and A. Trindade MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha Gastroenterology 135 2008 1624 1635.e24
109. Z. Bian, L. Li, and J. Cui Role of miR-150-targeting c-Myb in colonic epithelial disruption during dextran sulphate sodium-induced murine experimental colitis and human ulcerative colitis J Pathol 225 2011 544 553
110. T. Takagi, Y. Naito, and K. Mizushima Increased expression of microRNA in the inflamed colonic mucosa of patients with active ulcerative colitis J Gastroenterol Hepatol 25 Suppl 1 2010 S129 S133
111. M. Fasseu, X. Tréton, and C. Guichard Identification of restricted subsets of mature microRNA abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease PloS One 5 2010 e13160
112. F. Wu, S. Zhang, and T. Dassopoulos Identification of microRNAs associated with ileal and colonic Crohn's disease Inflamm Bowel Dis 16 2010 1729 1738
113. P. Brest, P. Lapaquette, and M. Souidi A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn's disease Nat Genet 43 2011 242 245
114. F. Wu, N.J. Guo, and H. Tian Peripheral blood microRNAs distinguish active ulcerative colitis and Crohn's disease Inflamm Bowel Dis 17 2012 241 250
115. A.M. Zahm, M. Thayu, and N.J. Hand Circulating microRNA is a biomarker of pediatric Crohn disease J Pediatr Gastroenterol Nutr 53 2011 26 33
116. P. Archanioti, M. Gazouli, and G. Theodoropoulos Micro-RNAs as regulators and possible diagnostic bio-markers in inflammatory bowel disease J Crohn's Colitis 5 2011 520 524
117. C.G. Bell, S. Finer, and C.M. Lindgren Integrated genetic and epigenetic analysis identifies haplotype-specific methylation in the FTO type 2 diabetes and obesity susceptibility locus PloS One 5 2010 e14040
118. G. Toperoff, D. Aran, and J.D. Kark Genome-wide survey reveals predisposing diabetes type 2-related DNA methylation variations in human peripheral blood Hum Mol Genet 21 2012 371 383
119. B. Tycko Allele-specific DNA methylation: beyond imprinting Hum Mol Genet 19 2010 R210 R220
120. H.-M. Byun, K.D. Siegmund, and F. Pan Epigenetic profiling of somatic tissues from human autopsy specimens identifies tissue- and individual-specific DNA methylation patterns Hum Mol Genet 18 2009 4808 4817
121. M. Okubo, T. Tahara, and T. Shibata Association study of common genetic variants in pre-microRNAs in patients with ulcerative colitis J Clin Immunol 31 2011 69 73
122. T. Ushijima, T. Nakajima, and T. Maekita DNA methylation as a marker for the past and future J Gastroenterol 41 2006 401 407
123. H.M. Müller, M. Oberwalder, and H. Fiegl Methylation changes in faecal DNA: a marker for colorectal cancer screening? Lancet 363 2004 1283 1285
124. W.A. Palmisano, K.K. Divine, and G. Saccomanno Predicting lung cancer by detecting aberrant promoter methylation in sputum Cancer Res 60 2000 5954 5958
125. E. Dulaimi Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel Clin Cancer Res 10 2004 1887 1893
126. S.L. Rosas, W. Koch, and M.G. da Costa Carvalho Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients Cancer Res 61 2001 939 942
127. K. Miyamoto, and T. Ushijima Diagnostic and therapeutic applications of epigenetics Jpn J Clin Oncol 35 2005 293 301
128. D. Azuara, F. Rodriguez-Moranta, and J. de Oca Novel methylation panel for the early detection of neoplasia in high-risk ulcerative colitis and Crohn's colitis patients Inflamm Bowel Dis 19 2013 165 173
129. R. Duttagupta, S. DiRienzo, and R. Jiang Genome-wide maps of circulating miRNA biomarkers for ulcerative colitis PloS One 7 2012 e31241
130. A. Paraskevi, G. Theodoropoulos, and I. Papaconstantinou Circulating microRNA in inflammatory bowel disease J Crohn's Colitis 6 2012 900 904
131. Z. Kanaan, S.N. Rai, and M.R. Eichenberger Plasma miR-21: a potential diagnostic marker of colorectal cancer Ann Surg 256 2012 544 551
132. K.T. Smith, and J.L. Workman Histone deacetylase inhibitors: anticancer compounds Int J Biochem Cell Biol 41 2009 21 25
133. J. Vojinovic, N. Damjanov, and C. D'Urzo Safety and efficacy of an oral histone deacetylase inhibitor in systemic-onset juvenile idiopathic arthritis Arthritis Rheum 63 2011 1452 1458
134. P. Vernia, V. Annese, and G. Bresci Topical butyrate improves efficacy of 5-ASA in refractory distal ulcerative colitis: results of a multicentre trial Eur J Clin Invest 33 2003 244 248
135. E.F. de Zoeten, L. Wang, and H. Sai Inhibition of HDAC9 increases T regulatory cell function and prevents colitis in mice Gastroenterology 138 2010 583 594
136. European Commission IBD Biom Available at: http://ec.europa.eu/research/ health/medical-research/severe-chronic-diseases/projects/ibd-biom-en.html 2012 Accessed March 1, 2013
137. European Commission IBD Character Available at: http://ec.europa.eu/ research/health/medical-research/severe-chronic-diseases/projects/ ibd-character-en.html 2012 Accessed March 1, 2013
138. H. Renz, E. von Mutius, and P. Brandtzaeg Gene-environment interactions in chronic inflammatory disease Nat Immunol 12 2011 273 277
139. R. Margueron, and D. Reinberg Chromatin structure and the inheritance of epigenetic information Nat Rev Genet 11 2010 285 296
140. M. Scarpa, and E. Stylianou Epigenetics: concepts and relevance to IBD pathogenesis Inflamm Bowel Dis 18 2012 1982 1996
141. B. Korman, D.L. Kastner, and P.K. Gregersen STAT4: genetics, mechanisms, and implications for autoimmunity review for current allergy and asthma reports Curr Allergy Asthma Rep 8 2009 398 403
142. E.F. Remmers, R.M. Plenge, and A.T. Lee STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus N Engl J Med 357 2007 977 986
143. A. Martínez, J. Varadé, and A. Márquez Association of the STAT4 gene with increased susceptibility for some immune-mediated diseases Arthritis Rheum 58 2008 2598 2602
144. L.M. Diaz-Gallo, R.J. Palomino-Morales, and M. Gómez-García STAT4 gene influences genetic predisposition to ulcerative colitis but not Crohn's disease in the Spanish population: a replication study Hum Immunol 71 2010 515 519
145. J. Glas, J. Seiderer, and M. Nagy Evidence for STAT4 as a common autoimmune gene: rs7574865 is associated with colonic Crohn's disease and early disease onset PloS One 5 2010 e10373
146. A.-K. Abelson, A.M. Delgado-Vega, and S.V. Kozyrev STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk Ann Rheum Dis 68 2009 1746 1753
147. S.W. Kim, E.S. Kim, and C.M. Moon Abnormal genetic and epigenetic changes in signal transducer and activator of transcription 4 in the pathogenesis of inflammatory bowel diseases Dig Dis Sci 57 2012 2600 2607
148. H.-J. Shin, H.-Y. Park, and S.-J. Jeong STAT4 expression in human T cells is regulated by DNA methylation but not by promoter polymorphism J Immunol 175 2005 7143 7150
149. A. Zwiers, L. Kraal, and T.C.T.M. van de Pouw Kraan Cutting edge: a variant of the IL-23R gene associated with inflammatory bowel disease induces loss of microRNA regulation and enhanced protein production J Immunol 188 2012 1573 1577
150. M. Parkes, J.C. Barrett, and N. Prescott Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn disease susceptibility Nat Genet 39 2009 830 832
151. Z. Lin, J.P. Hegarty, and J.A. Cappel Identification of disease-associated DNA methylation in intestinal tissues from patients with inflammatory bowel disease Clin Genet 80 2011 59 67
152. H.T.T. Nguyen, G. Dalmasso, and Y. Yan MicroRNA-7 modulates CD98 expression during intestinal epithelial cell differentiation J Biol Chem 285 2010 1479 1489
153. A.V. Olaru, F.M. Selaru, and Y. Mori Dynamic changes in the expression of MicroRNA-31 during inflammatory bowel disease-associated neoplastic transformation Inflamm Bowel Dis 17 2011 221 231
154. J.R. Pekow, U. Dougherty, and R. Mustafi miR-143 and miR-145 are downregulated in ulcerative colitis: putative regulators of inflammation and protooncogenes Inflamm Bowel Dis 18 2012 94 100